Pires, Ivan S. https://orcid.org/0000-0002-4035-0027
Covarrubias, Gil
Gomerdinger, Victoria F. https://orcid.org/0000-0003-1122-0482
Backlund, Coralie https://orcid.org/0000-0002-8012-8340
Nombera Bueno, Eduardo https://orcid.org/0009-0005-1247-7708
Billingsley, Margaret M.
Pryor, Mae https://orcid.org/0000-0002-7211-8150
Shanker, Apoorv
Gordon, Ezra https://orcid.org/0009-0002-6023-2789
Wu, Shengwei https://orcid.org/0000-0001-8175-3490
Pickering, Andrew J. https://orcid.org/0000-0002-1496-7752
Melo, Mariane B. https://orcid.org/0000-0002-0409-2454
Suh, Heikyung
Irvine, Darrell J. https://orcid.org/0000-0002-8637-1405
Hammond, Paula T. https://orcid.org/0000-0002-9835-192X
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01CA235375)
Foundation for the National Institutes of Health (F99CA274651)
Foundation for the National Institutes of Health (R01CA235375)
MIT | Deshpande Center for Technological Innovation, Massachusetts Institute of Technology
Howard Hughes Medical Institute
Ragon Institute of MGH, MIT and Harvard
Article History
Received: 18 March 2024
Accepted: 1 October 2025
First Online: 31 October 2025
Competing interests
: I.S.P., P.T.H. and D.J.I. are inventors on a patent filed by the Massachusetts Institute of Technology relating to these LbL NP therapeutics. The other authors declare no competing interests.